Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies in major markets. As…
